For years the standard advice was "the lowest dose for the shortest time," and many women were taken off hormone therapy at five years or at 60 regardless of how they were doing. That blanket rule has been walked back by menopause societies, but it is still what a lot of women are told. Here is what current guidance actually says, how to stop if you decide to, and what to expect afterward.

Where we stand: Menova is an independent publication. We sell no hormones, we are not your doctor, and this is general education, not medical advice. Never start, stop, or change a dose without the clinician who prescribed it.

Is there a time limit?

No fixed one. Current guidance from menopause societies is that there is no arbitrary maximum duration or age at which hormone therapy must be stopped. The decision is individual, reviewed periodically, and based on your symptoms, your risk profile, and your preferences.

What replaced the old rule is an annual conversation: are the benefits still outweighing the risks for you, at this dose, in this form, at this age?

Two things do shift with time, and they belong in that conversation honestly:

  • The risk profile changes with age and years of use. Some risks — particularly with combined estrogen-plus-progestogen therapy — are associated with longer duration of use.
  • Starting age matters more than duration. Guidance consistently distinguishes women who begin therapy under 60 or within ten years of menopause from those who start later, when the balance is less favorable. This is often called the timing hypothesis, and it is why "when did you start" is a more important question than "how long have you been on it."

When staying on it is standard

Two situations where continuing is usually the expected course rather than the exception:

  • Early or premature menopause. Women with premature ovarian insufficiency or early menopause are generally advised to continue hormone therapy at least until the average age of natural menopause — around 51 — because the relevant comparison is not an older woman on HRT, it is a woman of the same age with normal hormone levels. See early and surgical menopause.
  • Local vaginal estrogen. Because it acts locally and symptoms return when it stops, ongoing use is normal. See is vaginal estrogen safe.

Reasons women decide to stop

All legitimate, and worth naming so the decision is yours rather than default:

  • Symptoms have genuinely settled and you want to test whether you still need it
  • Side effects you would rather not carry
  • A change in your health that shifts the balance — a new diagnosis, a cardiovascular event, a cancer diagnosis
  • You simply want to, which is a sufficient reason

How to stop: taper or stop outright?

Honestly, the evidence does not clearly favor one. Studies comparing abrupt stopping with gradual tapering have not shown a consistent difference in whether symptoms return over the longer term.

What tapering does appear to help with is the short-term rebound — stopping abruptly can bring hot flashes back sharply within days, which is unpleasant and leads many women to restart in a panic rather than by decision. A gradual reduction over weeks to months makes the process easier to read.

A practical approach many clinicians use:

  • Reduce the dose in steps over several months rather than weeks
  • With patches, use a lower-strength patch or extend the interval as directed
  • With gels or sprays, reduce the number of pumps stepwise
  • Hold at each step for four to eight weeks before reducing again
  • Keep brief notes on what returns and how strongly

Two practical notes: if you have a uterus and are on combined therapy, do not stop the progestogen while continuing estrogen — the two are managed together. And stopping in winter is easier than stopping in July, if you have the choice.

What actually happens when you stop

Set expectations properly, because surprise is what drives most rushed restarts:

  • Hot flashes and night sweats often return, at least temporarily. For some women they settle within weeks; for others they persist. Return of symptoms is not a sign you did it wrong.
  • Sleep often worsens first, which then drags mood and concentration with it.
  • Vaginal and urinary symptoms usually return and continue, because that tissue change is ongoing — this is the one area where many women stay on local treatment even after stopping systemic therapy.
  • Bone loss resumes. The protective effect on bone density does not persist after stopping, which matters for your longer-term plan — see bone health in menopause.

Give it two to three months before judging. If symptoms are still disruptive at that point, restarting or trying a different approach is a legitimate decision, not a failure of willpower.

If you stop and symptoms are unmanageable

You have options beyond "back to exactly what I was on":

  • A lower dose, which is often enough
  • A different form — many women tolerate transdermal better than oral; see HRT types and forms
  • Non-hormonal prescription options, which are genuinely effective for some women; see non-hormonal menopause options
  • Local vaginal estrogen alone, if the remaining problems are vaginal or urinary

The annual review to actually have

Once a year, whether or not your clinician initiates it, the questions worth going through:

  • Are my symptoms still present when I skip a dose or reduce?
  • Has anything in my health or family history changed that alters the balance?
  • Is my dose and form still the right one, or should we adjust?
  • What is the plan if I want to try stopping — and how will we know whether it worked?

Bring notes. Our free printable visit prep sheet works for a review appointment as well as a first one, and our guides to HRT risks and benefits and what the first three months look like cover the rest of the decision.

Decide it, do not drift into it

The worst version of this is stopping abruptly because a pharmacy ran out, or being taken off at an arbitrary milestone without a conversation. Both are common, and both leave women worse off than a considered decision either way.

If you want a baseline before you change anything, the free 2-minute Menova self-check gives you a printable summary of the symptoms you report — useful for comparing against three months later. No account, not a diagnosis, and your answers never leave your device.

Related: HRT in your 60s and beyond, when symptoms return after stopping, what the WHI actually found, when you can't decide, and what monitoring actually involves.

This article is general education, not medical advice. Duration, tapering, and stopping decisions depend on your individual history — make them with the licensed clinician who prescribed your treatment, and report any unexpected bleeding.

Sources: The Menopause Society, NICE NG23 — Menopause, ACOG, and NHS — HRT.